GENE ONLINE|News &
Opinion
Blog

2020-07-27| PartnerAsia-Pacific

The Rise of Asia as a Destination of Biotech Investment and Opportunity

by Sangeeta Chakraborty
Share To
Dr. Monica He, Senior Director, International Affairs, BIO moderated the session “Asian opportunities and collaboration” that featured distinguished panelists discussing the collaborative opportunities and business models in the pharma and biotech sector of Asia while also touching upon the impact of the pandemic on the future.

GO Prime with only $1.49 now

LATEST
Healthcare Through the Eyes of AI: Coding the Future of Medicine Through Digital Acceleration
2025-03-21
European Pharmaceutical Review Highlights RNA Therapeutics and Process Analytical Technology in 2025 Issue 1
2025-03-21
Study Examines Long-Term Effects of Anti-Amyloid Drug for Rare Alzheimer’s Variant
2025-03-21
Sanofi Acquires Bispecific Drug Candidate in $600 Million Deal Focused on Autoimmune Disorders
2025-03-21
Trump Administration Policies May Impact Health Care for Intersex Individuals
2025-03-21
Federal Health Care Research Agency Faces Potential Mass Layoffs
2025-03-21
Police and Hospitals’ Drug Confiscation Practices Examined
2025-03-21
EVENT
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
Scroll to Top